ROCM:
Analysis & Opinions
-
January 03, 2013
On January 2, Zacks Investment Research downgraded Hospira, Inc. (HSP) to a Zacks #5 Rank (Strong Sell). Why the ...
-
March 13, 2012
If you're looking for cutting-edge companies that have a chance to triple or quadruple in the coming months and ...
